Last reviewed · How we verify

Anesthesia (Lidocaine 15%) — Competitive Intelligence Brief

Anesthesia (Lidocaine 15%) (Anesthesia (Lidocaine 15%)) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic. Area: Anesthesia.

marketed Local anesthetic Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Anesthesia (Lidocaine 15%) (Anesthesia (Lidocaine 15%)) — Lumbini Medical College. Lidocaine blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses to produce local anesthesia.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Anesthesia (Lidocaine 15%) TARGET Anesthesia (Lidocaine 15%) Lumbini Medical College marketed Local anesthetic Voltage-gated sodium channels
Xylocaine with Epinephrine Xylocaine with Epinephrine Vrije Universiteit Brussel marketed Local anesthetic with vasoconstrictor Voltage-gated sodium channels; alpha-1 adrenergic receptors
Tegretol® Tegretol® University of Malaya marketed Anticonvulsant; mood stabilizer Voltage-gated sodium channels
Xylocaine and Dexamethasone Xylocaine and Dexamethasone University of Jordan marketed Local anesthetic + corticosteroid combination Voltage-gated sodium channels (lidocaine); glucocorticoid receptor (dexamethasone)
Plain bupivacaine Plain bupivacaine Fayoum University Hospital marketed Local anesthetic Voltage-gated sodium channels
Exparel Injectable Solution Exparel Injectable Solution The Cooper Health System marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels
Exparel Injectable Product Exparel Injectable Product Pacira Pharmaceuticals, Inc marketed Local anesthetic (liposomal formulation) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic class)

  1. University of California, San Diego · 3 drugs in this class
  2. Durect · 3 drugs in this class
  3. Pacira Pharmaceuticals, Inc · 3 drugs in this class
  4. Wake Forest University Health Sciences · 3 drugs in this class
  5. Medical University of Vienna · 3 drugs in this class
  6. Imperial College London · 2 drugs in this class
  7. Hvidovre University Hospital · 2 drugs in this class
  8. Innocoll · 2 drugs in this class
  9. George Washington University · 2 drugs in this class
  10. Guy's and St Thomas' NHS Foundation Trust · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Anesthesia (Lidocaine 15%) — Competitive Intelligence Brief. https://druglandscape.com/ci/anesthesia-lidocaine-15. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: